[1
]
Neuro-Oncology Unit, Neurology Department, Hospital Universitari de Bellvitge-Institut
Català d´Oncologia-IDIBELL, C/Feixa Llarga s/n, L´Hospitalet de Llobregat, 08907,
Barcelona, Spain.
[2
]
Neurology Department, Hospital Universitari Mútua de Terrassa, Terrassa, Barcelona,
Spain.
[3
]
Medical Oncology Department, Institut Català d´Oncologia-IDIBELL, CIBERONC, L'Hospitalet
de Llobregat, Barcelona, Spain.
[4
]
Service de Neuro-Oncologie, Hospices Civils de Lyon, Groupe Hospitalier Est, Lyon
Cedex, France.
[5
]
Department of Cell Biology, Physiology and Immunology, Institute of Neurosciences,
Universitat Autònoma de Barcelona, and Centro de Investigación Biomédica en Red sobre
Enfermedades Neurodegenerativas (CIBERNED), Bellaterra, Spain.
[6
]
Neuro-Oncology Unit, Neurology Department, Hospital Universitari de Bellvitge-Institut
Català d´Oncologia-IDIBELL, C/Feixa Llarga s/n, L´Hospitalet de Llobregat, 08907,
Barcelona, Spain. rvelascof@bellvitgehospital.cat.
[7
]
Department of Cell Biology, Physiology and Immunology, Institute of Neurosciences,
Universitat Autònoma de Barcelona, and Centro de Investigación Biomédica en Red sobre
Enfermedades Neurodegenerativas (CIBERNED), Bellaterra, Spain. rvelascof@bellvitgehospital.cat.